Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous ...

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars ... Novo launched the NovoPen - the first insulin pen device in 1985. 2000–2017 Lars Rebien Sorensen becomes CEO after serving ...

A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names Ozempic (pre-filled pen) and Rybelsus (oral tablet) for type II diabetes (T2D), and Wegovy ...

All doses will be delivered with a once-weekly single-dose pen. Novo Nordisk’s direct-to-consumer ... year when the FDA officially moved both Ozempic and Wegovy off the shortage list, finding ...

Hims & Hers Health announced on Tuesday it will bundle Wegovy with the telehealth platform’s membership through a new collaboration with drugmaker Novo Nordisk ... quality pen for self-pay ...

Patients should only obtain Ozempic with a valid prescription through state-licensed pharmacies and check the product for counterfeiting before using, Novo Nordisk advised. There have been six ...

May 16 (Reuters) - Ozempic-maker Novo Nordisk (NOVOb.CO), opens new tab on Friday ousted ... Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after ...